Treatment of totally occluded saphenous vein grafts using self-expanding stents

Coronary Artery Disease

Volumn 13, Issue 7, 2002, Pages 373-376

  Aggarwal, Atul ^a,b   Terrien, Edward F ^a   Terrien Jr , Christopher M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MCHV Campus ^*  (United States)

Author keywords

Graft; Saphenous; Stent; Vein

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BALLOON; CASE REPORT; DEVICE; GUIDE WIRE; HUMAN; MALE; PRESSURE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAPHENOUS VEIN GRAFT; STENT; TECHNIQUE; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VEIN OCCLUSION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; SAPHENOUS VEIN; STENTS; THROMBOLYTIC THERAPY;

EID: 0036874928     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200211000-00004     Document Type: Article

References (20)

1. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition, and prevention. Circulation 1998; 97:916-931.
2. Bourassa MG. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol 1991; 17:1081-1083.
3. Hamby RI, Aintablian A, Handler M, Voleti C, Weisz D, Garvey JW, et al. Aortocoronary saphenous vein bypass grafts. Long-term patency, morphology and blood flow in patients with patent grafts early after surgery. Circulation 1979; 60:901-909.
4. Lytle BW, Loop FD, Cosgrove DM, Taylor PC, Goormastic M, Peter W, et al. Fifteen hundred coronary reoperations. Results and determinants of early and late survival. J Thorac Cardiovasc Surg 1987; 93:847-859.
5. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89:2514-2518.
6. Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999; 34:468-475.
7. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001; 38:659-665.
8. Holmes DR, Jr, Topol EJ, Califf RM, Berdan LG, Lexa F, Berger PB, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II investigators. Circulation 1995; 91:1966-1974.
9. Strauss BH, Natarajan MK, Batchelor WB, Yardley DE, Bittl JA, Sanborn TA, et al. Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. Circulation 1995; 92:348-356.
10. Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carozza JP, Sharma S, et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol 2002; 89:326-330.
11. Carlino M, De Gregorio J, Di Mario C, Anzuini A, Airoldi F, Albiero R, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999; 99:3221-3223.
12. Grube E, Gerckens U, Yeung AC, Rowold S, Kirchof N, Sedgewick J, et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001; 104:2436-2441.
13. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105:r13-r18.
14. Dauerman HL, Prpic R, Andreou C, Popma JJ. Resolution of coronary thrombus with rescue stenting. Am J Cardiol 2000; 85:1244-1247.
15. Roguin A, Grenadier E, Linn S, Markiewicz W, Beyar R. Continued expansion of the nitinol self-expanding coronary stent: angiographic analysis and 1-year follow-up. Am Heart J 1999; 138:326-333.
16. Mak K, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ. Effect of platelet glycoprotein IIb-IIla receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997; 80:985-988.
17. Mathew V, Grill DE, Scott CG, Grantham JA, Ting HH, Garratt KN, et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol 1999; 34:1163-1169.
18. Safian RD, Kaplan B, Schreiber T, Waters J, Moses J, Leon MH. Final results of the randomized wallstent endoprosthesis in saphenous vein graft trial (WINS). J Am Coll Cardiol 1999; 33:37A.
19. Safian RD, Kaplan B, Schreiber T, Waters J, Moses J, Leon MH. Final results of the Wallstent endoprosthesis in large saphenous vein graft (WINS registry). J Am Coll Cardiol 1999; 33:51A.
20. Uretsky BF, Kussmaul W, Buchbinder M, George B, Braden G. Initial results with the Aegis Vortex system, a new aspiro-atherectomy system with distal embolization protection, in the treatment of saphenous vein grafts. J Am Coll Cardiol 2001; 37:45A.